New possibilities of pharmacotherapy for chronic obstructive pulmonary disease
The use of bronchodilators (DB) remains up to the present day the leading therapeutic strategy for the treatment of chronic obstructive pulmonary disease (COPD), in which case administration of fixed-dose combinations of long-acting bronchodilators seem the most promising. At the same time, the issu...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2018-10-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/2668 |